Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Jonas Korlach, Michael Rhodes

Premium

Pacific Biosciences has appointed Jonas Korlach to chief scientific officer, a position previously held by Eric Schadt. Schadt will remain a key scientific advisor to the company.

Korlach was previously scientific fellow at PacBio, supporting commercial development of the PacBio RS system and performing research aimed at developing new applications for the system. He is a co-inventor of single molecule real-time sequencing technology along with Stephen Turner.

Prior to joining PacBio, Korlach was a postdoctoral researcher at Cornell University. He holds a PhD and MS in biochemistry, molecular and cell biology from Cornell; and an MS and BA in biological sciences from Humboldt University in Berlin, Germany.


Michael Rhodes has left his position at Life Technologies to join NanoString Technologies as director of collaboration and applications development, where he will focus on digital gene expression.

Rhodes held various positions at Life Tech, including most recently as senior manager sequencing portfolio. He joined Applied Biosystems in 1999 in the genetic analysis division before the company was acquired by Life Tech.

In his new position, he will report to Joe Beechem, who recently joined NanoString from Life Tech, where he was most recently vice president, head of advanced sequencing and head of global sequencing chemistry, biochemistry, and biophysics.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.